Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 26;134(38):15732-42.
doi: 10.1021/ja302193u. Epub 2012 Sep 12.

Density variant glycan microarray for evaluating cross-linking of mucin-like glycoconjugates by lectins

Affiliations
Free PMC article

Density variant glycan microarray for evaluating cross-linking of mucin-like glycoconjugates by lectins

Kamil Godula et al. J Am Chem Soc. .
Free PMC article

Abstract

Interactions of mucin glycoproteins with cognate receptors are dictated by the structures and spatial organization of glycans that decorate the mucin polypeptide backbone. The glycan-binding proteins, or lectins, that interact with mucins are often oligomeric receptors with multiple ligand binding domains. In this work, we employed a microarray platform comprising synthetic glycopolymers that emulate natural mucins arrayed at different surface densities to evaluate how glycan valency and spatial separation affect the preferential binding mode of a particular lectin. We evaluated a panel of four lectins (Soybean agglutinin (SBA), Wisteria floribunda lectin (WFL), Vicia villosa-B-4 agglutinin (VVA), and Helix pomatia agglutin (HPA)) with specificity for α-N-acetylgalactosamine (α-GalNAc), an epitope displayed on mucins overexpressed in many adenocarcinomas. While these lectins possess the ability to agglutinate A(1)-blood cells carrying the α-GalNAc epitope and cross-link low valency glycoconjugates, only SBA showed a tendency to form intermolecular cross-links among the arrayed polyvalent mucin mimetics. These results suggest that glycopolymer microarrays can reveal discrete higher-order binding preferences beyond the recognition of individual glycan epitopes. Our findings indicate that glycan valency can set thresholds for cross-linking by lectins. More broadly, well-defined synthetic glycopolymers enable the integration of glycoconjugate structural and spatial diversity in a single microarray screening platform.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of two major binding modes between mucins and multidomain lectin receptors. (A) The oligomeric macrophage galactose-type lectins (MGLs) of dendritic cells form discrete adhesion complexes with MUC1 overexpressed on cancer cells. (B) Galectin-1 cross-linking of the mucin-type glycoprotein CD43 and CD7 triggers apoptosis in T-cells.
Figure 2
Figure 2
Schematic of mucin mimetic glycopolymer arrays. (A) Traditional glycan arrays rely on two-dimensional arrangements of monovalent glycans with very little control over spatial organization. (B) Glycan presentation on polymeric scaffolds more closely mimics that in native mucins. (C) Left: serine- and threonine-rich domains decorated with branched glycans initiating with a core sugar, α-N-acetylgalactosamine (α-GalNAc), are the hallmark of mucins. Right: a mucin-mimetic domain generated by oxime ligation of α-aminooxy-GalNAc to a poly(methylvinyl ketone) backbone.
Scheme 1
Scheme 1. Synthesis of Mucin Mimetics
Figure 3
Figure 3
Determination of cross-linking by lectins in mucin mimetic arrays. (A) Cross-linking by lectin does not occur and the observed dissociation constant should be independent of glycolpolymer surface density. (B) Cross-linking is a contributing factor and increasing separation between neighboring mucin mimetic molecules should result in weaker binding (Kd,high and Kd,low denote apparent dissociation constants determined for a lectin in a high and a low glycopolymer surface density array, respectively).
Figure 4
Figure 4
Control of glycopolymer surface density in microarrays and a binding profile of SBA in the lowest density array. (A) Printing with solutions of polymers 6 at concentrations of 75, 150, and 400 nM afforded arrays with average polymer spacing (Δ) of ∼35, 25, and 13 nm, respectively. (B) Image of a portion of the lowest surface density array before (Cy3-channel) and after incubation with SBA-AF647 (100 nM in buffer). (C) Biding isotherms for SBA-AF647 to polymers 6 in the lowest surface density array. (D) Apparent Kd’s obtained for SBA-AF647 in the lowest density array plotted against GalNAc valency in 6. (**p < 0.01; p-value refers to a comparison of Kd’s for polymers 6a and 6e).
Figure 5
Figure 5
Determination of lectin cross-linking in variable ligand density arrays. (A) A drop in apparent Kd’s for binding of SBA to polymers 6ac in the highest surface density array (lowest Δ) corresponds to avidity enhancements due to cross-linking by SBA. No SBA cross-linking was observed for polymers 6d and e. Binding profiles for WFL (B), VVA (C), and HPA (D) indicate no cross-linking of polymers 6. A decrease in avidity for VVA and HPA in the highest density array is likely the result of steric interference between lectin molecules bound to proximal ligands (*p < 0.05, **p < 0.01, ⧫p > 0.05; p-values refer to comparison of Kd’s for each polymer in the lowest and highest density arrays).
Figure 6
Figure 6
Cross-linking by lectins in density variant arrays of low-valency glycopolymer 9. The lectins show different levels of avidity enhancements resulting from decreased interligand spacing (Δ) indicating their unique intrinsic ability to cross-link polymer 9. No measurable binding was observed for SBA in the lowest density array. RWFL, a reduced nonagglutinating form of WFL, showed no cross-linking activity (p-values refer to comparison of Kd’s for each lectin at the lowest and highest polymer density).
Figure 7
Figure 7
Quantitative precipitation of SBA and HPA by soluble glycopolymers 6b, 6e, and 9 with valencies of 92, 170, and 17 GalNAc residues, respectively. (A) Plot of glycopolymer concentrations (P1/2) necessary to affect half-maximal lectin precipitation as a function of glycopolymer valency. (B) Plot of the number of GalNAc residues per lectin molecule bound in precipitates at P1/2.
Figure 8
Figure 8
Crystal structures of SBA (A) and HPA (B) lectins in complex with GalNAc-containing ligands (left) and their proposed interactions with mucin mimetics (right). (A) A “bind-and-slide” mode has previously been proposed for the interaction of the tetrameric SBA lectin with mucin-type polyvalent glycoconjugates. (B) The strong, valency-independent association of HPA with mucin mimetics 6 is likely to occur through a “face-to-face” binding mechanism.
Figure 9
Figure 9
A mechanistic rationale for distinct cross-linking activities of SBA and HPA. (A) The reversible “bind-and-slide” mechanism allows for dynamic assembly of SBA along the polymer scaffold while maximizing binding interactions through cross-linking. (B) Strong “face-to-face” interactions of HPA with the glycopolymers may lead to the formation of kinetically trapped species with a limited number of unbound GalNAc residues available for cross-linking.

Similar articles

Cited by

References

    1. Lundquist J. J.; Toone E. J. Chem. Rev. 2002, 102, 555–578. - PubMed
    2. Mammen M.; Choi S.-K.; Whitesides G. M. Angew. Chem., Int. Ed. 1998, 37, 2754–2794. - PubMed
    3. Lee R. T.; Lee Y. C. Glycoconjugate J. 2000, 17, 543–551. - PubMed
    4. Kitov P. I.; Bundle D. R. J. Am. Chem. Soc. 2003, 125, 16271–16284. - PubMed
    1. Dam T. K.; Brewer C. F. Glycobiology 2010, 20, 270–279. - PubMed
    1. Weis W. I.; Taylor M. E.; Drickamer K. Immunol. Rev. 1998, 163, 19–34. - PubMed
    1. Saeland E.; van Vliet S. J.; Bäckström M.; van den Berg V. C. M.; Geijtenbeek T. B. H.; Meijer G. A.; van Kooyk Y. Cancer Immunol. Immunother. 2007, 56, 1225–1236. - PMC - PubMed
    2. Napoletano C.; Rughetti A.; Agervig Tarp M. P. A.; Coleman J.; Bennet P. E.; Picco G.; Sale P.; Denda-Nagai K.; Irimura T.; Mandel U.; Clausen H.; Frati L.; Taylor-Papadimitriou J.; Burchell J.; Nuti M. Cancer Res. 2007, 67, 8358–8367. - PubMed
    1. Hollingsworth M. A.; Swanson B. J. Nat. Rev. Cancer 2004, 4, 45–60. - PubMed

Publication types